Respiratory Syncytial Virus (RSV) News and Research

RSS
Respiratory syncytial virus (RSV) causes mild, cold-like symptoms in adults and older children. However, it can cause serious problems in young babies, including pneumonia and severe breathing problems. In rare cases it can lead to death. Premature babies and those with other health problems have the highest risk. A child with RSV may have a fever, stuffy nose, cough and trouble breathing. Tests can tell if your child has the virus.
GenVec announces grant for respiratory syncytial virus vaccine program

GenVec announces grant for respiratory syncytial virus vaccine program

New weapon against respiratory syncytial virus

New weapon against respiratory syncytial virus

Discovery of quick method for making human monoclonal antibodies against flu

Discovery of quick method for making human monoclonal antibodies against flu

Study confirms link between colds and ear infections

Study confirms link between colds and ear infections

More needs to be done for preemie healthcare

More needs to be done for preemie healthcare

Risk factors for severe RSV infection in immunocompromised children

Risk factors for severe RSV infection in immunocompromised children

FDA clears for ProFlu+ test for marketing

FDA clears for ProFlu+ test for marketing

FDA clears test for 12 specific respiratory viruses

FDA clears test for 12 specific respiratory viruses

Scientists find predisposition to bronchiolitis in some babies

Scientists find predisposition to bronchiolitis in some babies

Medimmune announces phase 2 safety data for anti-RSV antibody

Medimmune announces phase 2 safety data for anti-RSV antibody

Dexamethasone steroid treatment shows no benefit for kids with bronchiolitis

Dexamethasone steroid treatment shows no benefit for kids with bronchiolitis

Steroid medications don't work in treating lower respiratory infections in children

Steroid medications don't work in treating lower respiratory infections in children

Biota and MedImmune announce clinical trial for respiratory syncytial virus antiviral drug

Biota and MedImmune announce clinical trial for respiratory syncytial virus antiviral drug

New vaccine breakthrough for respiratory syncytial virus

New vaccine breakthrough for respiratory syncytial virus

Child infections are an increasing concern in affluent countries

Child infections are an increasing concern in affluent countries

Protecting infants from viral infections may prevent the development of asthma late in childhood

Protecting infants from viral infections may prevent the development of asthma late in childhood

Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma

Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma

Weak immune response critical to disease that causes most infant hospitalizations

Weak immune response critical to disease that causes most infant hospitalizations

Biofunctional organic nanocrystals for quantitative detection of pathogen deoxyribonucleic acid

Biofunctional organic nanocrystals for quantitative detection of pathogen deoxyribonucleic acid

Researchers step toward therapy for respiratory syncytial virus

Researchers step toward therapy for respiratory syncytial virus